BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onyango IG, Jauregui GV, Čarná M, Bennett JP Jr, Stokin GB. Neuroinflammation in Alzheimer's Disease. Biomedicines 2021;9:524. [PMID: 34067173 DOI: 10.3390/biomedicines9050524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Li X, Luo G, Wang J, Li R, Zhou C, Wan T, Yang F. Pyroptosis as a candidate therapeutic target for Alzheimer’s disease. Front Aging Neurosci 2022;14:996646. [DOI: 10.3389/fnagi.2022.996646] [Reference Citation Analysis]
2 Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G. Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells 2022;11:2728. [DOI: 10.3390/cells11172728] [Reference Citation Analysis]
3 Hernández-Rodríguez M, Clemente CF, Macías-Pérez ME, Rodríguez-Fonseca RA, Vázquez MIN, Martínez J, Ruvalcaba RM, Rosas MM, Jiménez EM. Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology. Pharmacol Rep 2022. [PMID: 36042131 DOI: 10.1007/s43440-022-00405-9] [Reference Citation Analysis]
4 Schreiner TG, Creangă-murariu I, Tamba BI, Lucanu N, Popescu BO. In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease. Biomolecules 2022;12:1136. [DOI: 10.3390/biom12081136] [Reference Citation Analysis]
5 Barczuk J, Siwecka N, Lusa W, Rozpędek-kamińska W, Kucharska E, Majsterek I. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment. IJMS 2022;23:8979. [DOI: 10.3390/ijms23168979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Oumata N, Lu K, Teng Y, Cavé C, Peng Y, Galons H, Roques BP. Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules. Eur J Med Chem 2022;240:114578. [PMID: 35841881 DOI: 10.1016/j.ejmech.2022.114578] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schreiner TG, Menéndez-González M, Popescu BO. The "Cerebrospinal Fluid Sink Therapeutic Strategy" in Alzheimer's Disease-From Theory to Design of Applied Systems. Biomedicines 2022;10:1509. [PMID: 35884814 DOI: 10.3390/biomedicines10071509] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Y, Cheng X, Li H, Hui S, Zhang Z, Xiao Y, Peng W. Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease. Front Immunol 2022;13:908076. [PMID: 35720333 DOI: 10.3389/fimmu.2022.908076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rajesh Y, Kanneganti TD. Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease. Cells 2022;11:1885. [PMID: 35741014 DOI: 10.3390/cells11121885] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Huda TI, Diaz MJ, Gozlan EC, Chobrutskiy A, Chobrutskiy BI, Blanck G. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease. J Alzheimers Dis 2022. [PMID: 35662120 DOI: 10.3233/JAD-220119] [Reference Citation Analysis]
11 Hindle A, Singh SP, Pradeepkiran JA, Bose C, Vijayan M, Kshirsagar S, Sawant NA, Reddy PH. Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? IJMS 2022;23:6098. [DOI: 10.3390/ijms23116098] [Reference Citation Analysis]
12 Panchal SK, John OD, Mathai ML, Brown L. Anthocyanins in Chronic Diseases: The Power of Purple. Nutrients 2022;14:2161. [PMID: 35631301 DOI: 10.3390/nu14102161] [Reference Citation Analysis]
13 Piątkowska-chmiel I, Herbet M, Gawrońska-grzywacz M, Dudka J. Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes. IJMS 2022;23:5502. [DOI: 10.3390/ijms23105502] [Reference Citation Analysis]
14 Acioglu C, Heary RF, Elkabes S. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases. Brain Behav Immun 2022;102:163-78. [PMID: 35176442 DOI: 10.1016/j.bbi.2022.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wareham LK, Liddelow SA, Temple S, Benowitz LI, Di Polo A, Wellington C, Goldberg JL, He Z, Duan X, Bu G, Davis AA, Shekhar K, Torre AL, Chan DC, Canto-soler MV, Flanagan JG, Subramanian P, Rossi S, Brunner T, Bovenkamp DE, Calkins DJ. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00524-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Kubicova L, Bachmann G, Weckwerth W, Chobot V. (±)-Catechin—A Mass-Spectrometry-Based Exploration Coordination Complex Formation with FeII and FeIII. Cells 2022;11:958. [DOI: 10.3390/cells11060958] [Reference Citation Analysis]
17 Barbalho SM, Direito R, Laurindo LF, Marton LT, Guiguer EL, Goulart RDA, Tofano RJ, Carvalho ACA, Flato UAP, Capelluppi Tofano VA, Detregiachi CRP, Bueno PCS, Girio RSJ, Araújo AC. Ginkgo biloba in the Aging Process: A Narrative Review. Antioxidants 2022;11:525. [DOI: 10.3390/antiox11030525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Feng T, Hu X, Fukui Y, Bian Z, Bian Y, Sun H, Takemoto M, Yunoki T, Nakano Y, Morihara R, Abe K, Yamashita T, Shoji M. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer’s Disease with Chronic Cerebral Hypoperfusion. JAD 2022. [DOI: 10.3233/jad-215246] [Reference Citation Analysis]
19 Hu J, Wang X. Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link. Front Cell Neurosci 2022;15:811852. [DOI: 10.3389/fncel.2021.811852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wirianto M, Wang CY, Kim E, Koike N, Gomez-Gutierrez R, Nohara K, Escobedo G Jr, Choi JM, Han C, Yagita K, Jung SY, Soto C, Lee HK, Morales R, Yoo SH, Chen Z. The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model. FASEB J 2022;36:e22186. [PMID: 35120261 DOI: 10.1096/fj.202101633R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Toledo ARL, Monroy GR, Salazar FE, Lee JY, Jain S, Yadav H, Borlongan CV. Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. Int J Mol Sci 2022;23:1184. [PMID: 35163103 DOI: 10.3390/ijms23031184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Hughes FM, Allkanjari A, Odom MR, Jin H, Purves JT. Specialized pro-resolution mediators in the bladder: Receptor expression and recovery of bladder function from cystitis. Exp Biol Med (Maywood). [DOI: 10.1177/15353702211067465] [Reference Citation Analysis]
23 Milanesi E, Dobre M, Cucos CA, Rojo AI, Jiménez-Villegas J, Capetillo-Zarate E, Matute C, Piñol-Ripoll G, Manda G, Cuadrado A. Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's Disease. J Inflamm Res 2021;14:6085-102. [PMID: 34848989 DOI: 10.2147/JIR.S334337] [Reference Citation Analysis]
24 Pan Y. Nutrients, Cognitive Function, and Brain Aging: What We Have Learned from Dogs. Med Sci (Basel) 2021;9:72. [PMID: 34842769 DOI: 10.3390/medsci9040072] [Reference Citation Analysis]
25 Gupta M, Weaver DF. Axonal plasma membrane-mediated toxicity of cholesterol in Alzheimer's disease: A microsecond molecular dynamics study. Biophys Chem 2021;281:106718. [PMID: 34808480 DOI: 10.1016/j.bpc.2021.106718] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Andrieux P, Chevillard C, Cunha-Neto E, Nunes JPS. Mitochondria as a Cellular Hub in Infection and Inflammation. Int J Mol Sci 2021;22:11338. [PMID: 34768767 DOI: 10.3390/ijms222111338] [Reference Citation Analysis]
27 Regenthal R, Rong P, Krügel U. Nutraceuticals in mental diseases - Bridging the gap between traditional use and modern pharmacology. Curr Opin Pharmacol 2021;61:62-8. [PMID: 34628304 DOI: 10.1016/j.coph.2021.08.017] [Reference Citation Analysis]
28 Scuderi C, Golini L. Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention. Animals (Basel) 2021;11:2584. [PMID: 34573549 DOI: 10.3390/ani11092584] [Reference Citation Analysis]
29 Sánchez-Melgar A, Izquierdo-Ramírez PJ, Palomera-Ávalos V, Pallàs M, Albasanz JL, Martín M. High-Fat and Resveratrol Supplemented Diets Modulate Adenosine Receptors in the Cerebral Cortex of C57BL/6J and SAMP8 Mice. Nutrients 2021;13:3040. [PMID: 34578918 DOI: 10.3390/nu13093040] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Womersley JS, Spies G, Tromp G, Seedat S, Hemmings SMJ. Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women. J Neurovirol 2021. [PMID: 34448146 DOI: 10.1007/s13365-021-01009-4] [Reference Citation Analysis]
31 Norman K, Haß U, Pirlich M. Malnutrition in Older Adults-Recent Advances and Remaining Challenges. Nutrients 2021;13:2764. [PMID: 34444924 DOI: 10.3390/nu13082764] [Reference Citation Analysis]